Mark A. Behlke

Directeur Technique/Scientifique/R&D chez

Integrated DNA Technologies, Inc.

Consumer Services

Health Technology

Process Industries

Profil

Mark A. Behlke is the founder of Dicerna Pharmaceuticals, Inc. which was founded in 2007.
He is currently the Chief Scientific Officer at Integrated DNA Technologies, Inc. Dr. Behlke has a doctorate degree from Washington University in St. Louis which he received in 1988 and an undergraduate degree from Massachusetts Institute of Technology which he received in 1981.

Postes actifs de Mark A. Behlke

Sociétés	Poste	Début
Integrated DNA Technologies, Inc. Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and markets nucleic acid products	Directeur Technique/Scientifique/R&D	-

Tous les postes actifs de Mark A. Behlke

Anciens postes connus de Mark A. Behlke

Sociétés	Poste	Fin
DICERNA PHARMACEUTICALS, INC.	Fondateur	-

Voir l'expérience en détail de Mark A. Behlke

Formation de Mark A. Behlke

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark A. Behlke

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Washington University in St. Louis Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases	Health Technology
Integrated DNA Technologies, Inc. Integrated DNA Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and markets nucleic acid products	Process Industries
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance